ArticleHormones & cancer2013

Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation.

Kristi L Hoffman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.